Region: Global
Category: Life Sciences

Global Life Sciences

(45,012 reports matching your criteria)
  • Plastic Films

    ... CAGR of 5.8% over the analysis period 2024-2030. LLDPE Material, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$93.5 Billion by the end of the analysis ... Read More

  • Dental Laboratories

    ... CAGR of 5.4% over the analysis period 2024-2030. Systems & Parts, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$20.6 Billion by the end of the ... Read More

  • Orphan Drugs

    ... CAGR of 12.0% over the analysis period 2024-2030. Biologic Drugs, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$308.5 Billion by the end of the analysis ... Read More

  • ADME-Toxicology Testing

    ... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the ... Read More

  • Autologous Matrix-Induced Chondrogenesis (AMIC)

    ... 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Collagen Material, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$175.6 Million by the ... Read More

  • Automotive Upholstery

    ... CAGR of 7.6% over the analysis period 2024-2030. Synthetic Leather Material, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.7 Billion by the end of the ... Read More

  • Cardiac POC Testing Devices

    ... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.6 Billion by ... Read More

  • Catalyst Carriers

    ... growing at a CAGR of 4.8% over the analysis period 2024-2030. Ceramics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach 95 Million Kilograms by the end ... Read More

  • DevOps

    ... 17.3% over the analysis period 2024-2030. DevOps Solutions, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$19.9 Billion by the end of the analysis period. Growth ... Read More

  • Generic Drugs

    ... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More

  • Home Health Hubs

    ... at a CAGR of 33.3% over the analysis period 2024-2030. Standalone Hub, one of the segments analyzed in the report, is expected to record a 31.4% CAGR and reach US$2.9 Billion by the end of ... Read More

  • In Situ Hybridization (ISH)

    ... 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.1 ... Read More

  • Neuromodulation

    ... 9.2% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis period. ... Read More

  • Orthopedic Veterinary Implants

    ... at a CAGR of 6.7% over the analysis period 2024-2030. Veterinary Bone Plates, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$86.4 Million by the end ... Read More

  • Plastic Surgery Instruments

    ... at a CAGR of 7.6% over the analysis period 2024-2030. Handheld Instruments, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$930.8 Million by the end of ... Read More

  • Portable Ultrasound Equipment

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Cart / Trolley-Based Ultrasound Equipment, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.4 Billion by ... Read More

  • Soldier Systems

    ... CAGR of 4.8% over the analysis period 2024-2030. Personal Protection Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$3.8 Billion by the end of the ... Read More

  • RNA Analysis / Transcriptomics

    ... 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. RNA Analysis / Transcriptomics Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and ... Read More

  • Nanotechnology

    ... 11.3% over the analysis period 2024-2030. Nanocomposites, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$80.8 Billion by the end of the analysis period. Growth in ... Read More

  • Nanopatterning

    ... 17.7% over the analysis period 2024-2030. UV Nanoimprint Lithography Technology, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$6.2 Billion by the end of the analysis ... Read More

  • Medical Tourism

    ... CAGR of 13.2% over the analysis period 2024-2030. Cardiovascular Treatment, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$47.1 Billion by the end of the analysis ... Read More

  • Marine Biotechnology

    ... CAGR of 8.4% over the analysis period 2024-2030. Biomaterials, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$6.5 Billion by the end of the analysis period. ... Read More

  • Coatings for Medical Devices

    ... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Anti-Microbial Coatings, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$7.7 Billion by the ... Read More

  • Biosensors

    ... 7.2% over the analysis period 2024-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth ... Read More

  • Laboratory Reagents

    ... CAGR of 6.1% over the analysis period 2024-2030. Molecular Biology Application, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$17.0 Billion by the end of the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings